| Literature DB >> 29739928 |
Cuini Wang1, Yuanyuan Cheng1, Biao Liu2,3, Yuanyuan Wang4, Weiming Gong1, Yihong Qian1, Zhifang Guan1, Haikong Lu1, Xin Gu1, Mei Shi1, Pingyu Zhou5,6.
Abstract
The aim of this work was to investigate the application of the nested PCR assay for the detection of Treponema pallidum (TP) DNA from the blood of patients with different stages of syphilis. In this study, a nested PCR method targeting the Tpp47 and polA genes (Tpp47-Tp-PCR and polA-Tp-PCR) was developed to detect TP-DNA in whole blood samples collected from 262 patients with different stages of syphilis (84 primary syphilis, 97 secondary syphilis, and 81 latent syphilis patients). The PCR assay detected T. pallidum DNA in 53.6% and 62.9% of the patients with primary and secondary syphilis, respectively, which was much higher than the detection levels in patients with latent syphilis (7.4%) (both p < 0.001). For primary syphilis, a low RPR (0-16) was correlated with a higher detection rate of TP-DNA, whereas for secondary syphilis, the higher detection rate of blood TP-DNA was correlated with higher blood RPR titers (at or beyond 32). For latent syphilis, TP-DNA was only detectable by PCR in the early phase of the latent infection. Thus, blood RPR titers were correlated with the blood T. pallidum burden, but the correlations varied with primary and secondary syphilis. The results indicate that nested PCR is a sensitive method for detecting blood TP-DNA and is especially useful for detecting early syphilis including primary syphilis and secondary syphilis. The findings also suggest that the PCR assay may be used to complement other methods to enhance the diagnosis of syphilis.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29739928 PMCID: PMC5940865 DOI: 10.1038/s41426-018-0085-2
Source DB: PubMed Journal: Emerg Microbes Infect ISSN: 2222-1751 Impact factor: 7.163
Clinical characteristics of the 262 syphilis patients examined in this study
| Variable | Primary syphilis | Secondary syphilis | Latent syphilis |
|---|---|---|---|
| Patient number, | 84 | 97 | 81 |
| Age (median, IQR), years | 50 (32–58) | 35 (28–52) | 44 (32–56) |
| Male gender, | 75 (89.3) | 71 (73.2) | 44 (54.3) |
| Blood TPPA, | 76 (90.5) | 97 (100) | 81 (100) |
| Blood RPR, | 68 (81.0) | 97 (100) | 81 (100) |
| 1/Serum RPR titer (median, IQR) | 8 (1–64) | 64 (32–128) | 16 (8–64) |
| HIV infection, | 5 (6.0) | 15 (15.5) | 2 (2.5) |
| CSF protein, g/l (median, IQR) | 424 (298–524)* | 303.5 (231.3–410) | 340 (236.5–524) |
| CSF WBC, /μl | 0 (0–4)* | 4 (0–8) | 1 (0–10) |
| CSF VDRL(+), | 1 (5.9)* | 9 (9.3) | 16 (19.8) |
| CSF TPPA(+), | 1 (5.9)* | 30 (30.9) | 35 (43.2) |
IQR, interquartile range; RPR, rapid plasma reagin; TPPA, T. palladium particle agglutination; VDRL, venereal disease research laboratory; WBCs, white blood cells.
*The number of CSF sample was 17 (n = 17).
Fig. 1The detection rate of T. pallidum DNA in blood samples from all patients by Tpp47-Tp-PCR and polA-Tp-PCR.
a The positive specimens of polA-Tp-PCR and/or Tpp47-Tp-PCR among all patients (n = 262). b The positive specimens of polA-Tp-PCR and/or Tpp47-Tp-PCR in the primary syphilis patients (n = 84). c The positive specimens of polA-Tp-PCR and/or Tpp47-Tp-PCR in the secondary syphilis patients (n = 97). d The positive specimens of polA-Tp-PCR and/or Tpp47-Tp-PCR in the latent syphilis patients (n = 81)
The relationship between the blood RPR titer and the presence of T. pallidum DNA for all syphilis patients
| No. of patients with primary syphilis ( | No. of patients with secondary syphilis ( | No. of patients with latent syphilis ( | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RPR titer | Tested | Tested | Tested | |||||||||
| 0–16 | 53 | 28 (52.8%) | 26 (49.1%) | 32 (60.4%) | 8 | 1 (12.5%) | 3 (37.5%) | 3 (37.5%) | 40 | 0 | 0 | 0 |
| 32–64 | 22 | 9 (40.9%) | 10 (45.5%) | 10 (45.5%) | 49 | 28 (57.1%) | 27 (55.1%) | 33 (67.3%) | 27 | 1 (3.7%) | 2 (7.4%) | 2 (7.4%) |
| ≥ 128 | 9 | 2 (22.2%) | 3 (33.3%) | 3 (33.3%) | 40 | 22 (55.0%) | 22 (55.0%) | 25 (62.5%) | 14 | 4 (28.6%) | 2 (14.3%) | 4 (28.6%) |
PolA(+), specimens positive for polA-Tp-PCR; RPR, rapid plasma reagin; Tpp47(+), specimens positive for Tpp47-Tp-PCR; PolA&Tpp47(+), specimens positive for polA-Tp-PCR and/or Tpp47-Tp-PCR.